Skip to main content
Clinical Trials/ACTRN12618001326280
ACTRN12618001326280
Recruiting
未知

Investigating the efficacy of continuous positive airway pressure (CPAP) in patients receiving radiotherapy treatment for centrally located lung cancers.

Auckland City Hospital0 sites20 target enrollmentAugust 7, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
ung Cancer
Sponsor
Auckland City Hospital
Enrollment
20
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 7, 2018
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who meet the following criteria will be eligible:
  • \-Aged 16 years or older.
  • \- Diagnosed with centrally located lung tumour, defined as within 2cm in all directions of any mediastinal critical structure, including the bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve and recurrent laryngeal nerve.
  • \- Prescribed (by an Radiation Oncology) a Radiotherapy Treatment of 60Gy in 8 fractions (SABR) or 48Gy in 12 fractions (hypofractionation).
  • \- Meets the current departmental inclusion criteria for a treatment prescription of 60Gy in 8 fractions (SABR) or 48Gy in 12 fractions (hypofractionation).

Exclusion Criteria

  • Patients that have significant comorbidities that may result in them not tolerating treatment with CPAP (recent surgery, respiratory conditions, inappropriate age, and disabilities).
  • Patients who are unable to provide informed consent or who refuse to use CPAP.

Outcomes

Primary Outcomes

Not specified

Similar Trials